Assessment of romiplostim immunogenicity in adult patients in clinical trials and in a global postmarketing registry.
Saved in:
| Title: | Assessment of romiplostim immunogenicity in adult patients in clinical trials and in a global postmarketing registry. |
|---|---|
| Authors: | Mytych DT; Amgen Inc., Thousand Oaks, CA, USA., Park JK; Amgen Inc., Thousand Oaks, CA, USA., Kim J; Amgen Inc., Thousand Oaks, CA, USA., Barger TE; Amgen Inc., Thousand Oaks, CA, USA., Boshier A; Amgen Ltd, Cambridge, UK., Jawa V; Amgen Inc., Thousand Oaks, CA, USA., Kuter DJ; Hematology Division, Massachusetts General Hospital, Boston, MA, USA. |
| Source: | British journal of haematology [Br J Haematol] 2020 Sep; Vol. 190 (6), pp. 923-932. Date of Electronic Publication: 2020 Apr 20. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
